InvestorsHub Logo
icon url

gharma

08/21/11 12:37 PM

#33291 RE: exogyra #33290

Not Brian here, but a couple cents to toss in.
I thought that Wilke (sp?) was attorney for Wanderport in matters of representation to the OTC market.
The statement of authorized shares answers, partly, but does not outline how. Read the last sentence (from the Q2 unaudited filing)

B. Common or Preferred Stock.
The authorized shares consist of 1,200,000,000 shares of common stock at $0.001 par value. There is no preferred
stock authorized. There are no provisions in issuer's charter or by-laws that would delay, defer or prevent a change in
control of the issuer.


Again, that matter comes down to with what Robert would align. Seems that would be the place to start, as going in blind on that part could be just so much wasted effort should he vote it down (with his 62.25% holding of issued).
icon url

TASBES0101

08/21/11 5:29 PM

#33293 RE: exogyra #33290

I have had some communication with Mr. Wilke but not in the matters you've mentioned. Others are working on some of these details though. Also, I'm not the leader. I'm just being vocal with my opinions and what I believe we need to position the company for the best possible outcome.

Go Wanderport!